The rapid progress of The Npwt Sector and the exit of Johnson & Johnson and Bristol-Myers Squibb has changed this sector fundamentally. Who are the players And technologies that are benefiting from these developments?
Key Areas Addressed:
Growth forecasts to 2013 for the major moist wound care, NPWT and biological wound care sectors and regions Market share data by company for major product sectors An examination of market and product growth drivers Extensive review of product ranges within each wound care sector Competitor reviews of 115 leading and developing companies
While the advanced wound care market has generally seen double-digit growth over the past five years, the growth rate slowed in 2008 and this trend is expected to continue in 2009 with a global valuation of US$4.9 billion in 2008.
The number of patients requiring treatments for chronic and challenging wounds has and will continue to rise. However, growth in terms of sales volumes is being affected by the higher number of companies entering this market, which is increasing competition and bringing down selling prices. In addition, the market is likely to see pressures on reimbursement levels as governments seek to rein in healthcare expenditure during the current economic downturn.
While several leading companies have added to their advanced wound care portfolios, two leading healthcare companies have exited this market: Johnson & Johnson (via Ethicon) and Bristol-Myers Squibb (via ConvaTec). For both companies, advanced wound care was not a key part of their overall operations and the move may have been timely, as market growth is slowing in their sector of interest and neither company had a presence in the rapidly-growing field of NPWT.
Key Topics Covered:
Executive Summary Overview Advanced Wound Care Market Competitors Advanced Wound Care Market Dynamics Advanced Wound Care Products & Technologies Device-Based Wound Care Moist Wound Care Products Biologics And Pharmaceuticals Other Products Manufacturers The Market Leaders Appendix 1 - List Of Abbreviations Appendix 2 - Report Methodology
Companies Mentioned:
Just Some of the 115 Companies Profiled:
3M Coloplast ConvaTec Covidien Hartmann Group Kinetic Concepts Medline Industries Molnlycke Health Care Smith & Nephew Systagenix Wound Management ACell Advitech Agennix AGT Sciences Archimed Argentum Medical Aspen Surgical Products Avita Medical B. Braun BioElectronics Biotec Pharmacon Boehringer Laboratories Care-Tech Laboratories Celleration Collagen Matrix Comvita Cytomedix
For more information visit http://www.researchandmarkets.com/research/0eed1c/all_change_in_the
Source: Espicom Business Intelligence Ltd
SOURCE: Research and Markets
Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com Fax (USA): 646-607-1907 Fax (International): +353-1-481-1716

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index